SCHEMBL18859601

SCHEMBL18859601

c1ccc2cc(-c3c4ccccc4c(-c4ccc(-c5nc6sc7ccccc7c6c6ccccc56)cc4)c4ccccc34)ccc2c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ELANE P08246 1/20 0.36
▸ NQO1 P15559 1/20 0.35
▸ NQO2 P16083 1/20 0.35
▸ MAPK8 P45983 1/20 0.33
▸ MAPK9 P45984 1/20 0.33
▸ MAPK10 P53779 1/20 0.33
▸ ESR1 P03372 2/20 0.33
▸ ESR2 Q92731 2/20 0.33
▸ CYP1A2 P05177 2/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ ADORA2A P29274 2/20 0.33
▸ ADORA1 P30542 2/20 0.33
▸ AR P10275 2/20 0.32
▸ HTR2B P41595 1/20 0.32
▸ HTR5A P47898 1/20 0.32
▸ IKBKB O14920 1/20 0.32
▸ ALDH1A1 P00352 2/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18859620 0.91 ESR1 (0.39) ELANENQO1NQO2MAPK8MAPK9
SCHEMBL18859614 0.86 HSD17B1 (0.39) ELANENQO1NQO2MAPK8MAPK9
SCHEMBL18859608 0.84 ELANE (0.34) ELANENQO1NQO2ESR1ESR2
SCHEMBL18859626 0.83 NQO2 (0.38) ELANENQO1NQO2MAPK8MAPK9
SCHEMBL18803208 0.80 ELANE (0.40) ELANECYP1A2SMN1; SMN2ADORA2AALDH1A1
SCHEMBL18859549 0.80 TNKS (0.38) NQO1NQO2MAPK8MAPK9MAPK10
SCHEMBL18859691 0.80 NQO1 (0.35) ELANENQO1NQO2CYP1A2SMN1; SMN2
SCHEMBL18859678 0.79 ELANE (0.36) ELANESMN1; SMN2ALDH1A1HPGDMAPT
SCHEMBL18859780 0.78 MAPT (0.38) ELANECYP1A2SMN1; SMN2ADORA2AADORA1
SCHEMBL22274507 0.78 ELANE (0.37) ELANEALDH1A1NPSR1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10644244-B2 Heterocyclic compound and organic light emitting device using same LT MATERIALS CO., LTD. (KR) 2020-05-05 — — US disclosed
US-20170141325-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME HEESUNG MATERIAL LTD. (KR) 2017-05-18 — — US disclosed
US-20170141325-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME HEESUNG MATERIAL LTD. (KR) 2017-05-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170141325-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME CRY1, CRY2, CYBA ELANE 4401/4885NQO1 70/4885NQO2 1849/4885
US-10644244-B2 Heterocyclic compound and organic light emitting device using same CRY1, CRY2, CYBA ELANE 4401/4885NQO1 70/4885NQO2 1849/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback